A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use

NCT02336139 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

103

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Sofosbuvir (SOF)/GS-5816

Sponsor

Kirby Institute